Skip to content

US · BFRGW · MEDICAL - HEALTHCARE INFORMATION SERVICES

Bullfrog AI Holdings, Inc. Warrants (BFRGW) intrinsic value and stock valuation

$0.10as of 2026-11-21 · Mkt cap 1.42M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Bullfrog AI Holdings, Inc. Warrants DCF and intrinsic value

InvestorsCraft values BFRGW with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BFRGW’s statements →

Bullfrog AI Holdings, Inc. Warrants Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Medical - Healthcare Information Services Gaithersburg, MD 20878 bullfrogai.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$120K
20202025
Net income
-$-6.5M
20202025
Free cash flow
-$-5.52M
20202025
Total equity
$2.14M
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$120K$0.00$70K$10K$0.00
Operating income-$-6.59M-$-7.24M-$-5.37M-$-2.46M-$-560K
Net income-$-6.5M-$-6.99M-$-5.36M-$-2.8M-$-590K
EPSd-$-628.63K-$-847.27K-$-885.95K-$-459.77K-$-104.42K
Operating cash flow-$-5.52M-$-5.61M-$-6M-$-910K-$-380K
Capital expenditure-$0.00$0.00$0.00-$-10K$0.00
Free cash flow-$-5.52M-$-5.61M-$-6M-$-920K-$-380K
Total assets$2.81M$5.55M$2.78M$80K$10K
Total debt$0.00$0.00$0.00$1.58M$590K
Net debt-$-2.18M-$-5.44M-$-2.62M$1.52M$580K
Total equity$2.14M$4.96M$2.59M-$-3.06M-$-1.01M
Cash and short-term investments$2.18M$5.44M$2.62M$60K$10K
Income statement
20252024202320222021
Revenue$120K$0.00$70K$10K$0.00
Cost of revenue$100K$0.00$10K$0.00$0.00
Gross profit$20K$0.00$60K$10K$0.00
Research and development expenses$1.8T$2.22M$1.43M$610K$30K
Selling, general and administrative expenses$4.82T$5.01M$3.99M$1.86M$530K
Other expenses-$-6.62T$0.00$0.00$0.00$0.00
Operating expenses$6.61M$7.24M$5.43M$2.46M$560K
Cost and expenses$6.71M$7.24M$5.43M$2.47M$560K
Interest income$100K$260K$180K$0.00$0.00
Interest expense$10K$20K$80K$350K$40K
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Ebitda-$-6.49M-$-6.97M-$-5.28M-$-2.45M-$-550K
Operating income-$-6.59M-$-7.24M-$-5.37M-$-2.46M-$-560K
Total other income/expenses, net$100K$240K$10K-$-350K-$-30K
Income before tax-$-6.5M-$-6.99M-$-5.36M-$-2.8M-$-590K
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-6.5M-$-6.99M-$-5.36M-$-2.8M-$-590K
Weighted average shares outstanding$10.3M$8.25M$6.05M$6.09M$5.65M
Weighted average diluted shares outstanding$10.3M$8.25M$6.05M$6.09M$5.65M
Balance sheet
20252024202320222021
Cash and short-term investments$2.18M$5.44M$2.62M$60K$10K
Net receivables$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$2.58M$5.55M$2.77M$70K$10K
Property, plant and equipment, net$0.00$0.00$10K$10K$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$220K$0.00$0.00$0.00$0.00
Total non-current assets$220K$0.00$10K$10K$0.00
Total assets$2.81M$5.55M$2.78M$80K$10K
Accounts payable$170K$440K$100K$540K$70K
Short-term debt$0.00$0.00$0.00$1.58M$590K
Deferred revenue$0.00$0.00$0.00$30K$10K
Total current liabilities$670K$590K$180K$3.14M$1.02M
Long-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$0.00$0.00$0.00$0.00
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$670K$590K$180K$3.14M$1.02M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-23.29M-$-16.79M-$-9.75M-$-4.4M-$-1.6M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$2.14M$4.96M$2.59M-$-3.06M-$-1.01M
Total investments$220K$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$0.00$1.58M$590K
Net debt-$-2.18M-$-5.44M-$-2.62M$1.52M$580K
Cash flow statement
20252024202320222021
Net income-$-6.5M-$-6.99M-$-5.36M-$-2.8M-$-590K
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Stock-based compensation$1.01M$940K$630K$340K$100K
Change in working capital$80K$440K-$-1.44M$1.14M$100K
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-270K$330K-$-440K$480K-$-30K
Net cash provided by operating activities-$-5.52M-$-5.61M-$-6M-$-910K-$-380K
Investments in property, plant and equipment$0.00$0.00$0.00-$-10K$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$0.00$0.00$0.00-$-10K$0.00
Common stock issued$2.47M$8.32M$7.29M$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$2.37M$8.42M$8.57M$970K$390K
Net change in cash-$-3.15M$2.81M$2.57M$50K$0.00
Cash at end of period$2.29M$5.44M$2.62M$60K$10K
Operating cash flow-$-5.52M-$-5.61M-$-6M-$-910K-$-380K
Capital expenditure-$0.00$0.00$0.00-$-10K$0.00
Free cash flow-$-5.52M-$-5.61M-$-6M-$-920K-$-380K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Bullfrog AI Holdings, Inc. Warrants

        Bullfrog AI Holdings, Inc., along with its various subsidiaries, operates as a digital biopharmaceutical company. Its core business involves leveraging artificial intelligence (AI) and machine learning (ML) to meticulously analyze medical and healthcare datasets within the United States. The company's proprietary offering, bfLEAP, is an advanced AI/ML platform specifically designed for processing and interpreting both preclinical and clinical research data. Furthermore, Bullfrog AI has secured significant licensing agreements. One agreement with George Washington University grants them the rights to employ siRNA (small interfering RNA) targeting Beta2-spectrin for treating diverse human conditions, including but not limited to hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Another key accord with Johns Hopkins University authorizes the use of a specialized Mebendazole formulation for the therapeutic treatment of human cancers or other neoplastic diseases. Founded in 2017, Bullfrog AI Holdings, Inc. is headquartered in Gaithersburg, Maryland.

        CEO
        Vininder Singh
        Employees
        9
        Beta
        0.40

        Explore

        Frequently asked questions

        What is the intrinsic value of Bullfrog AI Holdings, Inc. Warrants (BFRGW)?

        InvestorsCraft does not currently publish an intrinsic value for BFRGW. How the IC value is calculated.

        Is BFRGW undervalued?

        InvestorsCraft does not publish an undervaluation signal for BFRGW at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.